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Purpose/Objective: Several articles have been published comparing 
the results of Monte Carlo (MC) simulations with treatment planning 
system calculations, both generally and on a site-specific basis e.g. 
for prostate, head and neck and lung treatments. However, 
publications for oesophageal radiotherapy are rare, despite the fact 
that the treatment volume lies in a region of heterogeneous anatomy 
involving a number of organs at risk (e.g. spinal cord, heart, lung). 
The aim of this work is to develop an efficient framework for 
performing MC simulations of clinical oesophageal treatments, so that 
the results of a statistically significant number of clinical cases may 
be compared in order to evaluate the differences between planning 
algorithms as robustly as possible. 
Materials and Methods: Radical oesophageal radiotherapy plans are 
now routinely produced in our centre according to a protocol 
originally developed for the UK national SCOPE trial. Plans were 
performed using the Pencil Beam Enhanced (PBE) and Collapsed Cone 
Enhanced (CCE) algorithms within Nucletron Oncentra MasterPlan 
(OMP v3.3 Service Pack 1). The DICOM CT, Structure Set, Plan and 
Dose files are exported from OMP for clinical plans. Python scripts 
were used to anonymise the data, remove any private DICOM tags, and 
alter Region Of Interest (ROIs) to follow a specific naming convention. 
The anonymised DICOM files were uploaded to our RTGrid calculation 
platform, a system that creates MC input files from DICOM files,and 
allows MC simulations to be performed on distributed computing 
resources at Cardiff University, with the results from different 
computers being automatically combined by the RTGrid system. The 
RTGrid platform has recently been adapted to handle CT scans 
involving iodine-based contrast agents and the Enhanced Dynamic 
Wedge (EDW) for Varian Linear Accelerators (linacs). After simulation, 
the 3D dose matrices produced by RTGrid were converted from energy 
deposited per photon to Gray, following the method of Liu to account 
for backscatter to the monitor chamber of the linac. The 3D dose 
matrices were then converted to DICOM-RT DOSE files, following the 
method of Teke. The MC dose distributions can either be imported 
back into OMP or, using scripts written in Matlab, in to CERR, for 
calculation of Dose Volume Histograms (DVHs) and other plan metrics.  
Results: Initial results from the study to date indicate that the dose to 
95% of the Planning Target Volume (PTV) vary by up to 5%, with 
similar levels of difference in Organ at Risk (OAR) doses.  
Conclusions: A system has been developed to perform MC simulations 
of Oesophageal treatment plans with minimal user interaction. Initial 
investigations indicate that DVH parameters used in the reporting of 
Oesophageal treatment plans varies by up to 5% when comparing MC 
simulated dose distributions to those calculated from Treatment 
Planning algorithms.  
   
EP-1189   
The role of dose calculation methods in IMRT breast planning 
D. Mateus1, S. Vieira2, A. Soares1, E.C. Moser2, C. Greco2, J. Stroom2 
1Medical Consult, Radiotherapy, Lisboa, Portugal  
2Fundação Champalimaud, Radiotherapy, Lisboa, Portugal  
 
Purpose/Objective: The majority of our breast cancer patients are 
treated with fixed-angle IMRT, although VMAT is also available. Fixed-
angle plans fulfill the clinical objectives more closely, specially in the 
low dose levels. In recen tyears, more precise dose calculation 
algorithms became available for clinical practice. Our goal is to 
investigate for a group of breast cancer patients whether the use of a 
more precise dose calculation algorithm will affect the clinical choice 
of IMRT plans in our institution. 
Materials and Methods: Five left-sided breast cancer patients were 
selected from a group of patients already treated with fixed-angle 
IMRT in our institute. Left sided tumors were chosen in order to have 
more insight on the dose to the heart. The clinical plans of the five 
patients were generated using the ECLIPSE treatment planning system 
(version 10). Dose calculation was performed using the AAA 
convolution-based algorithm. Subsequently, the clinical plans were 
replanned using VMAT. First, the same clinical-and optimisation 
objectives were used as in the plan delivered to the patient. 
Secondly, the VMAT plans were optimized individually in order to 
produce the best possible plan. 
Finally, dose calculation was performed for all plans using ACUROSXB 
(a new deterministic-based algorithm), also available in ECLIPSE. The 
same calculation grid (0.25 cm) was applied. 
Results: Percentage differences between both VMAT and fixed-
angleIMRT are larger as compared with the dose calculation 
algorithms (see table 1.)This is largely due to the fact that the 
planning objectives used for the VMATplans were originally from the 
fixed-angle IMRT plan. In table 1 is also shown that once an 
individualized optimisation is performed for the VMAT plans, 
differences became much less pronounced. However, results obtained 
for each technique show that differences of 1-3% can be found at the 
lower dose regions (V5 Gy), especially in the lung region. Because 
doses to the heart are clinically evaluated in our institute at V10 Gy 
instead of the V5 Gy, the differences between all the plans for this 
organ seem to be less significant. 
 
 
Conclusions: Differences between the dose calculation algorithms 
indicate that the use of ACUROSXB may affect the clinical choice of 
the IMRT plan.  
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Purpose/Objective: Dose calculation algorithms might not model 
radiation dose distribution accurately in heterogeneous tissues (HT) 
such as lung and head and neck region. Latest techniques such as 
IMRT, IMAT and SRT produce sharp dose gradient by this means 
provide better dose coverage in target while reducing organs at risk 
(OARs) doses. Therefore accurate modeling is crucial to ensure 
sufficient target dose and OARs doses within tolerance limits in HT. 
This experimental and dosimetric study compared the dose 
distributions of Pencil Beam Convolution (PBC) and Anisotropic 
Analytical Algorithm (AAA) photon dose calculation algorithms in HT. 
Furthermore, IMRT plans calculated by both AAA and PBC were 
verified.  
Materials and Methods: 10 patients with non-small cell lung cancer, 
planned using IMRT were included. Primarily, all plans were 
calculated using Pencil Beam Convolution (PBC) algorithm and graded 
as reference plans. Than same plans were re-calculated using 
Anisotropic Analytical Algorithm (AAA). To ensure equal target dose 
coverage for both algorithms (PBC and AAA), dose normalization was 
made to the isodose, which is 95% of the target volume receiving 100% 
of the dose. OARs doses and maximum doses in the target between 
PBC and AAA plans were compared. Furthermore, all plans were 
delivered to homogeneous and heterogeneous phantoms and 
verification measurements made using a pinpoint ionization chamber. 
For each algorithm, calculated and actual doses were compared.  
Results: Max doses in the targets were higher for AAA than PBC plans 
(p=0.005); the differences were between 3.1-7.1%. Calculated OARs 
doses by PBC and AAA were significantly different for lung V5, V20 and 
Dmean (p values were 0.005, 0.005 and 0.013 respectively), for 
esophagus V55 and Dmean (p values were 0.005 for both criteria), and 
for heart V60 doses (p=0.043). Nevertheless, there was no significant 
difference for heart V20 (p=0.678) and spinal cord Dmax(p=0.114). 
Though, the differences for all OARs doses were less than 3%. 
Calculated and actual dose differences for homogeneous and 
heterogeneous phantoms were not significant for AAA plans (p=0.139 
andp=0.074), although were significant for PBC plans (p=0.007 and 
p=0.012). Mean difference was 1.6% in AAA and 2.4% in PBC plans for 
homogenous phantom whereas 2.6% in AAA and 6.1% in PBC plans for 
heterogeneous phantom.  
